A new study combines RNA origami and glass nanopores to achieve a 18-nucleotide resolution for diagnosing repeat expansion disorders like ALS.

One‑and‑done gene edit cut LDL up to 62%; Cleveland labs flag a nitric‑oxide Alzheimer clue. Experts caution on supplements.

Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene editing company developing transformative medicines for serious diseases, today announced that it has commenced an underwritten public offering ...

Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene editing company developing transformative medicines for serious diseases, today announced the pricing of an underwritten public offering of ...

Every human cell wears a sugary shell. This outer coat, called the glycocalyx, is built from chains of sugar molecules that ...

Pint of Science 2026 ran from May 18 to 20 across bars in Indian cities, mixing cold beer with rocket science, tattoo ...

For more than two decades, the genetics of autism seemed to splinter in every direction. Each new sequencing study added ...

New research published in Nature Communications is being shared freely to help scientists, farmers and brewers worldwide ...

An international team led by University of Manchester scientists has created the most detailed picture yet of how genetic differences shape the way the human eye works. The breakthrough could help ...

Scientists are beginning to understand how trillions of viruses interact with our bodies. This article explores key knowledge ...

A University of Texas at Austin-led team has reconstructed the most detailed map to date of the molecular machines that ...

Scientists have uncovered a surprising twist in how cells behave when division goes wrong. Sometimes a cell successfully copies its DNA but fails to split into two, leaving it with double the genetic ...